Low BMI and ESCC survival: nutritional immune mediation in a real world multicenter cohort
Bo Peng
,
Fangfang Liu
,
Wei Yang
,
Ruiping Xu
,
Lei Chen
,
Ji Ke
,
Wenlei Yang
,
Yu He
,
Zhen Liu
,
Bolin Hou
,
Liqun Zhang
,
Miaoping Lin
,
Lixin Zhang
,
Huawen Xu
,
Fan Zhang
,
Fen Cai
,
Mengfei Liu
,
Ying Liu
,
Yaqi Pan
,
Zhonghu He
,
Yang Ke
1. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Genetics, Peking University Cancer Hospital & Institute, Beijing 100142, China
2. Cancer Hospital of Shantou University Medical College, Shantou 515031, China
3. Anyang Cancer Hospital, Anyang, Henan Province 455000, China
4. Chinese Preventive Medicine Association, Beijing 100062, China
5. Linkdoc AI Research (LAIR), Beijing 100080, China
6. State Key Laboratory of Molecular Oncology, Department of Genetics, Peking University Cancer Hospital & Institute, Beijing 100142, China
Corresponding author:
zhonghuhe@foxmail.com
keyang@bjmu.edu.cn;
Show less
History+
Received
Accepted
Published Online
2026-02-27
2026-08-27
2026-11-17
PDF
(1641KB)
i
This article has been updated.A Correction to this article was published on .
Body mass index (BMI) has been inconsistently linked to prognosis in esophageal squamous cell carcinoma (ESCC), and mechanistic evidence remains limited. We evaluated the association of low BMI with ESCC outcomes, explored effect modification, and quantified mediation by nutrition–immune biomarkers. In this multicenter Chinese cohort of 9894 ESCC patients with up to 12 years of follow-up, BMI at admission was categorized as underweight (< 18.5 kg/m2) or non-underweight (≥ 18.5 kg/m2). Multivariable Cox models were used for survival analyses, with subgroup and mediation analyses performed subsequently. Overall, 12.7% of patients were underweight. Underweight was associated with poorer survival (median survival: 24.7 vs. 65.5 months; 5-year survival rate: 36.0% vs. 51.3%, with an observed 15.3 percentage point difference in 5-year survival; log-rank P < 2 × 10−16; adjusted hazard ratio (HRadjusted) =1.38, 95% confidence interval (CI): 1.28−1.50), particularly among males and alcohol users with significant interactions between BMI and sex (P = 0.021) and alcohol use (P = 0.013). Among 16 candidate biomarkers, six (including hemoglobin and albumin) explained 29.4% of the BMI–mortality association, suggesting partial mediation through nutritional and immune pathways. In surgically treated patients, underweight was also associated with increased postoperative complications (adjusted odds ratio (ORadjusted) =1.53, 95% CI: 1.23−1.90). Low BMI predicts adverse ESCC outcomes partly through nutrition–immune pathways.
This article has successfully passed peer review and final editorial review, and will soon enter typesetting, proofreading and other publishing processes. The currently displayed version is the accepted final manuscript. The officially published version will be updated with format, DOI and citation information upon launch. We recommend that you pay attention to subsequent journal notifications and preferentially cite the officially published version. Thank you for your support and cooperation.